InspireMD Inc expected to post a loss of 15 cents a share - Earnings Preview

InspireMD

03/11/2023 18:38

* InspireMD Inc  NSPR.OQ   NSPR.O  is expected to show a
rise in
quarterly revenue when it reports  results 
    * The Tel Aviv-yafo Israel-based   company is expected to
report 
a 3.7% increase in revenue to $1.485 million from $1.43 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for InspireMD Inc is
for a
loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InspireMD
Inc is
$4.85​, above​ its last closing price of $3.34. ​​​

This summary was machine generated November 3 at 18:38 GMT.  All
figures in US dollars  unless otherwise stated